Open AccessLimitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Author(s) -
Sonya Naryshkin,
Robert Marshall Austin
Publication year - 2012
Publication title -
drug healthcare and patient safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 24
ISSN - 1179-1365
DOI - 10.2147/dhps.s37273
Subject(s) - vial , medicine , human papillomavirus , cervical cancer , oncology , cytology , cervical cancer screening , concordance , cervical screening , gynecology , cancer , pathology , chemistry
To increase awareness of the limitations of high-risk human papillomavirus (hrHPV) laboratory-developed testing (LDT) widely used in US cervical cancer screening.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom